NCT04857151View on ClinicalTrials.gov

Stress, Inflammation and Immune Response Pilot Study- Aim 3

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

March 31, 2024

Conditions
Systemic Lupus ErythematosusInflammation
Interventions
BEHAVIORAL

App based mindfulness program (ABMP)

App based mindfulness program (ABMP)

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT04857151 - Stress, Inflammation and Immune Response Pilot Study- Aim 3 | Biotech Hunter | Biotech Hunter